The mission of The DOLF Project is to develop and test improved treatments for onchocerciasis and lymphatic filariasis that will enhance efforts to control and eliminate these important neglected tropical diseases.
NEWS & EVENTS
DOLF’s 2024 Year in Review
We are pleased to share a summary of our accomplishments of the past year.
Field Note: Portable qPCR thermocycler enables fast track xenomonitoring of mosquito vectors for DNA of the filarial parasite Brugia malayi in Indonesia
In December 2024, Dr. Irina Diekmann, a postdoctoral researcher at Washington University School of Medicine (WashU Med) joined Professor Taniawati Supali and her team at Universitas Indonesia (UI) in Jakarta, Indonesia. Irina travelled with a portable qPCR machine. While the laboratory in Jakarta already had access to real-time PCR equipment, standardization of assays was a […]
DOLF Leadership Visits Clinical Trial Sites in Liberia and Ivory Coast
The DOLF Project PI, Dr. Peter Fischer, and associate director Laura Peer traveled to Liberia in October for a mid-trial visit the site of DOLF’s clinical trial of treatment for the neglected tropical disease (NTD) onchocerciasis (also known as “river blindness”). The clinical trial is located at Bong Mines Hospital about 70 miles from the […]
